{"schema_version":"1","generated_at":"2026-11-17T00:52:34.439Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jennifer-dorth","json_url":"https://www.findmykol.com/kol/jennifer-dorth/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jennifer-dorth","name":"Jennifer Dorth","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University Hospitals of Cleveland","institution_url":"https://www.findmykol.com/institution/university-hospitals-of-cleveland","city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1518132463","orcid":"0000-0002-1112-3781","openalex":"A5011105999"},"summary":"Jennifer Dorth is an Oncology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 106 publications with 1,621 citations (h-index 21); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":106,"cited_by_count":1621,"h_index":21,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07425054","title":"ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Jennifer Dorth","source_url":"https://clinicaltrials.gov/study/NCT07425054","trial_url":"https://www.findmykol.com/trial/NCT07425054"},{"nct":"NCT04166318","title":"Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"ECOG-ACRIN Cancer Research Group","source_url":"https://clinicaltrials.gov/study/NCT04166318","trial_url":"https://www.findmykol.com/trial/NCT04166318"},{"nct":"NCT02153450","title":"Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer","phase":"EARLY_PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Case Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT02153450","trial_url":"https://www.findmykol.com/trial/NCT02153450"}],"source":"trials"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Nervous system","share_pct":100,"classes_total":2,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":64.4,"drugs":[{"name":"Oxycodone Hcl","share_pct":100}],"max_beneficiaries":20},{"class":"Gabapentinoids","setting":"prescribed","share_pct":35.6,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Patient‐reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma","year":2026,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.70345","status":"verified"},{"title":"Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline","year":2025,"journal":"Practical Radiation Oncology","source_url":"https://doi.org/10.1016/j.prro.2025.02.001","status":"verified"},{"title":"Stakeholder perspectives on the role of caregivers in cancer clinical trial decision-making: results of a qualitative study","year":2025,"journal":"Supportive Care in Cancer","source_url":"https://doi.org/10.1007/s00520-025-09505-7","status":"verified"},{"title":"Management of Locally Advanced Rectal Cancer: ASCO Guideline","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.24.01160","status":"verified"},{"title":"Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma","year":2024,"journal":"JAMA Oncology","source_url":"https://doi.org/10.1001/jamaoncol.2024.5403","status":"verified"}],"source":"works"},"contact":{"address_1":"11100 EUCLID AVE","city":"Cleveland","state":"OH","zip":"441061716","phone":"216-844-3951","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1518132463","source":"identity"},"similar":[{"name":"Sophia Sundararajan","slug":"sophia-sundararajan","institution":"University Hospitals of Cleveland","specialty":"Neurology","url":"https://www.findmykol.com/kol/sophia-sundararajan","json_url":"https://www.findmykol.com/kol/sophia-sundararajan/profile.json"},{"name":"Lloyd Greene","slug":"lloyd-greene","institution":"University Hospitals of Cleveland","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/lloyd-greene","json_url":"https://www.findmykol.com/kol/lloyd-greene/profile.json"},{"name":"Hans Luders","slug":"hans-luders","institution":"University Hospitals of Cleveland","specialty":"Neurology","url":"https://www.findmykol.com/kol/hans-luders","json_url":"https://www.findmykol.com/kol/hans-luders/profile.json"},{"name":"Ian Neeland","slug":"ian-neeland","institution":"University Hospitals of Cleveland","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/ian-neeland","json_url":"https://www.findmykol.com/kol/ian-neeland/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2012-12-10","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}